ABSTRACT A novel Bacillus subtilis KD1 strain was isolated and identified from healthy broilers, and its phylogenetic classification was subsequently analyzed. To evaluate its probiotic availability, its growth characteristics and tolerance for the gut environment were evaluated in vitro. The results suggest that B. subti lis KD1 is superior in secreting neutral protease and is highly tolerant of gastric acid and bile salt. In the logarithmic growth phase, the neutral protease reached a maximum of 1,369.3 U/mL. When all live bacteria had become spores in the broth, B. subtilis KD1 was freeze dried and fed to broilers at 10 9 , 5 × 10 9 , and 10 10 bacilli/kg of feed. The animal trial results suggest that the addition of the new strain significantly improved intestinal flora by increasing lactobacilli and reducing Escherichia coli (P < 0.05) as compared with the control; hence, B. subtilis KD1 is a promising probiotic organism in broilers. 
INTRODUCTION
Antibiotics have been used in the animal feed industry for decades. At low levels, they enhance the growth performance of farm animals. However, because of the emergence of microbes resistant to the antibiotics that are used to treat infections in humans and animals, many countries have banned the addition of antibiotics as growth promoters in animal diets (Aly et al., 2008; Sleator and Hill, 2008; Vasiljevic and Shah, 2008) . As a result, the focus of research in poultry diets for the optimization of gut health and animal performance has been shifting from antibiotics to antibiotic alternatives. Feeding domestic avian species with living microbial cultures to promote growth and improve the efficiency of feeds has attracted increasing interest in recent decades (Nahashon et al., 1994 (Nahashon et al., , 1996 Jin et al., 1997) . Many experiments have shown that probiotics play an important role in adjusting intestinal ecological imbalances and improving animal health.
The bacilli in animals produce various digestive enzymes for degrading the complex carbohydrates in plant feedstuffs and, thus, increase the feed conversion ratio (FCR; Anjum et al., 2005) . Many Bacillus species have been considered safe for use in food and livestock breeding (Jack et al., 1995; Paik et al., 1997) . Different from other bacteria, bacilli can be administered orally as cells or spores. Their vegetative cell and spore properties render them heat resistant and tolerant to bile salts (Gilliland et al., 1984) .
The main objective of the current study was to find a bacterial strain that can serve as an alternative to antibiotics. Six bacillus strains that produce neutral protease were isolated from healthy broilers and evaluated. To assess the probiotic availability of the strains, an in vitro evaluation of their growth characteristics and tolerance for the gut environment and an in vivo animal trial were conducted.
MATERIALS AND METHODS

Experimental Design
Potential probiotic strains should be validated by in vitro and in vivo tests before their practical application. Two experiments were conducted: 1) the in vitro experiment for screening and identifying the strains and evaluating their growth characteristics and tolerance for the gut environment, and 2) the in vivo experiment for evaluation of their effects on broiler intestinal flora via an animal trial.
Bacterial Strains
A total of 120 bacterial strains were isolated from the ileal digesta of 14-d-old killed broilers from 10 farms (Qingdao, Shandong, China). The 120 strains were evaluated on casein agar medium, from which 6 bacilli
Identification of Bacillus sp. KD1
Physiological and Biochemical Characterization. Optimum growth conditions (including temperature, pH, and salt concentration) were assessed by observing colony morphology, staining morphology, and growth characteristics on nutrient agar. Biochemical tests (e.g., glucose fermentation broth, Voges-Proskauer test, and indole test) were conducted to investigate the metabolism of various substrates and relevant metabolites. The Bacillus strain species were confirmed using Bergey's Manual of Determinative Bacteriology (Buchanan and Gibbons, 1984) and the molecular biology results.
Molecular Identification and Phylogenetic Analysis. The genomic DNA of the strains were extracted by G-spin genomic DNA extraction kit (Intron Biotechnology, Seongnam-Si, Korea) for 16S rRNA sequence amplification with bacteria universal primers (forward primer: 5′-AGAGTTTGATCCTGGCTCAG-3′; reverse primer: 5′-TACGGCTACCTTGTTACGAC-3′). The PCR procedure was as follows: 1 µL of DNA, 5 µL of 10× buffer (ExTaq buffer; Takara, Shiga, Japan), 4 µL of 2.5 mM deoxyribonucleotide triphosphate, 1 µL of each primer (20 pmol/µL), 0.25 µL of Taq polymerase (ExTaq; Takara), and 37.75 µL of distilled water. The amplification conditions were 30 cycles of 94°C for 40 s, 55°C for 40 s, and 72°C for 40 s and then an extra extension step of 72°C for 10 min. A 10-µL portion of the reaction mixture was resolved by electrophoresis in a 2% agarose gel to detect 307-bp amplicons. The PCR products were recovered and sequenced by Beijing Genomics Institute (China). The sequencing results were submitted online to the National Center for Biotechnology Information BLAST system (http://blast. ncbi.nlm.nih.gov/Blast.cgi).The similarity analysis of the most similar 16SrDNA sequences from 18 strains was conducted by Clustal X 1.8 software (Plate-Forme de Bio-Informatique, Illkirch Cedex, France) in accordance with the principle of maximum homology, and the phylogenetic trees were subsequently created with the neighbor-joining algorithm of Mega 4 software (Molecular Evolutionary Genetics Analysis 4, Center for Evolutionary Medicine and Informatics, Arizona State University, Tempe).
Growth Characteristics of Bacillus sp. KD1 and Its Tolerance for Artificial Gastric Juice and Intestinal Juice
Artificial intestinal (pH 6.8, 0.05 mol/L of KH 2 PO 4 solution with different concentration poultry bile salts) and gastric (0.016 mol/L of HCl solution with 1% pepsin) juices were sterilized using a filter membrane device. Logarithmic phase seed culture (1%) was inoculated into the special medium. Viable cells were counted after cultivation in a bath oscillator for 4 h.
Before the logarithmic phase, the seed was inoculated into the special medium prepared with artificial intestinal fluid for fermentation and then cultivated in a constant temperature shaker (160 rpm) for 24 h. The culture was sampled every 2 h and the optical density at 600 nm, pH, and neutral protease activity in the broth were measured. The growth, enzyme production, and pH curves of Bacillus sp. KD1 were illustrated using Origin 7.5 (OriginLab Corp., Northampton, MA). When all live bacteria in the broth had become spores, B. subtilis KD1 was freeze dried and stored at 4°C for the animal trial.
Birds, Diets, and Management
A total of 1,200 vaccinated (Marek's disease and infectious bronchitis) male broilers (1 d old) were obtained from a commercial hatchery. The birds were randomly divided into 8 treatment groups, with each group including 5 replicates of 30 broilers. The composition and nutrient analysis results for the basic diet are shown in Table 1 . The birds had free access to water and feed. The climatic conditions and lighting program were computer operated and followed the commercial recommendations. Environmental temperature in the first week of life was 35°C and decreased to 25°C until the end of the experiment. During the first week, 22 h of light was provided, with a reduction to 20 h afterward.
Bird Trial Design
A single-factor design was employed ( Table 2) . The trial included a blank control group, an antibiotic group, a Bacillus sp. YB group, and a Bacillus sp. KD1 group. Bacilli (Bacillus sp. YB and Bacillus sp. KD1) were added to the basal diet at 0.05, 0.25, and 0.5% of weight, which corresponded to 10 9 , 5 × 10 9 , and 10 10 bacilli/kg of feed. Maxus (avilamycin premix 20%, Elanco Animal Health, Greenfield, IN) was added at the recommended dosage (100 g/t). The trial lasted for 42 d.
Performance
Fifty broilers from each treatment group were randomly weighed on d 0, 21, and 42. Feed consumption was accurately recorded daily. Daily weight gain and FCR were calculated.
Sample Collection and Analysis
Fifty broilers from each treatment group were randomly selected on d 21 and 42. These broilers were killed using lethal amounts of carbon dioxide, and their rectums and ilea were removed under aseptic conditions. The samples were stored in sterile plastic tubes, placed in labeled boxes packed with ice, and immediately sent to our laboratory for plate counting of microorganisms (eosin methylene blue agar for Escherichia coli and de Man, Rogosa, and Sharpe agar for Lacto bacillus by pour plate method, including Escherichia coli and Lactobacillus, which were repeated thrice).
Statistical Analysis
Statistical analysis was conducted using SPSS for Windows Version 17.0 (SPSS Inc., Chicago, IL) to ascertain whether variables differed between groups. Experimental data were expressed as mean ± SD. Neutral protease activity, tolerance for bile and acid, and intestinal flora were compared between groups using 1-way ANOVA and subsequent Duncan's multiple range tests. Probability values less than 0.05 were considered significant.
RESULTS
Evaluation of Capability to Secrete Neutral Protease for Different Bacilli
The Bacillus strains YB, S201, SC4, KD1, KR01, and KR02 were evaluated for their capability to secrete neutral protease after incubation for 24 h. The results showed significant difference (P < 0.05), with Bacillus sp. KD1 demonstrating the highest yield at 1,087.79 U/mL (Figure 1 ). One protease unit is the quantity of enzyme needed to hydrolyze casein to 1 µg of tyrosine at certain temperature and pH in 1 min.
Identification of Bacillus sp. KD1
Physiological and Biochemical Identification. Table 3 lists the physiological and biochemical characteristics of Bacillus sp. KD1. The findings are consistent with Bacillus subtilis morphology as described in Bergey's Manual of Determinative Bacteriology (Buchanan and Gibbons, 1984) . The strain was initially identified as B. subtilis.
Molecular Biology Identification of B. subtilis KD1. The BLAST sequence alignment results showed that the 16S rRNA sequence of KD1 is 99% identical with that of B. subtilis strain F121112 (GenBank accession no. EF424289.1) and B. subtilis isolate BS-1 (GenBank accession no. AY172514.1). Both Bacillus sp. KD1 and B. subtilis isolate BS-1 belong to the same level of evolutionary relationship. Based on the physiological and biochemical identification, Bacillus sp. KD1 was confirmed as a B. subtilis strain. Figure 2 shows the stellate phylogenetic tree of B. subtilis KD1.
B. subtilis KD1 Tolerability for Artificial Gastric Juice and Intestinal Juice
Survival rates of B. subtilis KD1 and the control groups were significantly different at pH 2.0 (P < 0.05), whereas no significant difference was observed at pH 3.0 and pH 4.0 (P > 0.05; Figure 3) . Although significantly decreased at pH 2, the survival rate in the B. subtilis KD1 group was still in the same order of magnitude (10 7 ) as the control group.
As bile salt concentration increased, the survival rate of B. subtilis KD1 decreased accordingly and showed significant difference with that of the control group (P < 0.05; Figure 4) . The inhibitory effect of bile salts on B. subtilis KD1 was evident, but the total plate counts of the different treatment groups remained in the same order of magnitude (10 7 ) as the control group.
Growth and Metabolic Characteristics of B. subtilis KD1 During Fermentation
As shown in Figure 5 , the neutral protease activity gradually increased in the logarithmic growth phase, with the maximum value up to 1,369.3 U/mL (at 14 h) and gradually decreasing to the stable and decline phases. The highest activity of neutral protease of B. subtilis KD1 appeared in the late logarithmic phase (13-15 h). Thus, samples for the animal trial were taken from the broth during this period when the fermentation pH was stable at 7.0.
Effects of B. subtilis KD1 on Broiler Growth Performance
The ADG and FCR data from d 1 to 21 and from d 22 to 42 are presented in Table 4 . Bacillus subtilis KD1 significantly enhanced the ADG of broilers compared with that of the blank and YB groups (P < 0.05) from d 22 to 42, but not from d 1 to d 21 (P > 0.05). No significant difference of ADG was observed between KD1 groups and Maxus groups (P > 0.05). The FCR data suggested that KD1 groups had no significant difference from the blank groups and Maxus groups from d 1 to 42 (P > 0.05), whereas B. subtilis YB significantly (P < 0.05) enhanced the FCR of broilers from d 22 to 42 compared with that of the other groups.
Effects of B. subtilis KD1 on Broiler Intestinal Flora
The effects of B. subtilis KD1 on intestinal flora from d 1 to 21 and from d 22 to 42 are presented in Table  5 . Compared with the blank groups and YB groups, 
DISCUSSION
Probiotics should be able to withstand strong gastric acid and high bile salt concentrations before they colonize the intestines. Bacillus subtilis KD1 showed good tolerance for gastric acid and bile salt in the present study, which allowed the strain to maintain enough activity in the animal intestines. Many favorable effects are associated with the use of microbial probiotics in animal feeds (Fuller, 1973; Barrow et al., 1980; Reid, 1999) . Some involve in the competitive exclusion of pathogenic E. coli (Watkins et al., 1982) , Campylobacter jejuni (Morishita et al., 1997) , and Salmonella Enteritidis (Pascual et al., 1999) and increasing growth of beneficial gut microflora. The current study shows that lactobacilli in the intestinal tracts of broilers treated with 0.5% B. subtilis KD1 were at least 10-fold greater than those in the negative and antibiotic control groups (Maxus).
Although B. subtilis KD1 is not a principal member of the normal intestinal flora and could not colonize the intestines for long periods, it consumes oxygen rapidly and reduces pH, which favors lactobacilli and inhibits E. coli. On the other hand, although the contribution of the digestive enzymes secreted by B. subtilis KD1 in improving production performance in broilers is limited, the various nutrients yielded by these enzymes may contribute to population changes in intestinal bacteria to some extent.
For the past decades, antibiotic growth promoters have been included in poultry diets at subtherapeutic concentrations as standard practice worldwide because of their positive effects on BW, BW gain, and FCR. The results from the present study suggest that B. sub tilis KD1 isolated from the intestines of healthy broilers could be a promising probiotic organism for replacing antibiotic owing to good tolerance for gastric acid and bile salt, secreting abundant neutral protease, and improving the intestinal flora by significantly increasing Lactobacillus levels while reducing E. coli levels.
In conclusion, 6 bacillus strains that produce neutral protease were isolated from healthy broilers. Among them, B. subtilis KD1, which has the highest yield, has been identified, phylogenetically analyzed, and investigated for tolerability. Further observations of its effects on intestinal flora have shown that KD1 is a potential superior growth promoter compared with antibiotics.
